GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Price-to-Operating-Cash-Flow

Serina Therapeutics (Serina Therapeutics) Price-to-Operating-Cash-Flow : (As of Jun. 05, 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Price-to-Operating-Cash-Flow?

As of today (2024-06-05), Serina Therapeutics's share price is $9.35. Serina Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.29. Hence, Serina Therapeutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for Serina Therapeutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

SER's Price-to-Operating-Cash-Flow is not ranked *
in the Biotechnology industry.
Industry Median: 25.44
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

Serina Therapeutics's Cash Flow from Operations per share for the six months ended in Mar. 2024 was $-0.18. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.29.

Serina Therapeutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Serina Therapeutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Price-to-Operating-Cash-Flow Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22
Price-to-Operating-Cash-Flow
- -

Serina Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Mar24
Price-to-Operating-Cash-Flow - - - - -

Competitive Comparison of Serina Therapeutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Serina Therapeutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Serina Therapeutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Serina Therapeutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Serina Therapeutics's Price-to-Operating-Cash-Flow falls into.


Serina Therapeutics Price-to-Operating-Cash-Flow Calculation

Serina Therapeutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=9.35/-0.285
=

Serina Therapeutics's Share Price of today is $9.35.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Serina Therapeutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-0.29.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Serina Therapeutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics (Serina Therapeutics) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Price-to-Operating-Cash-Flow
Comparable Companies
Traded in Other Exchanges
2BO:Germany
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Website
https://www.serinatherapeutics.com
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines

From GuruFocus

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse� for Advanced Parkinson's Disease

By Marketwired • 05-15-2024